Parallel Advisors LLC Raises Stock Holdings in Mettler-Toledo International, Inc. $MTD

Parallel Advisors LLC boosted its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 37.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 284 shares of the medical instruments supplier’s stock after buying an additional 77 shares during the period. Parallel Advisors LLC’s holdings in Mettler-Toledo International were worth $334,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. WPG Advisers LLC acquired a new position in Mettler-Toledo International in the 1st quarter valued at about $41,000. Zions Bancorporation National Association UT acquired a new position in Mettler-Toledo International in the first quarter valued at approximately $43,000. Golden State Wealth Management LLC boosted its holdings in Mettler-Toledo International by 583.3% in the first quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier’s stock valued at $48,000 after purchasing an additional 35 shares in the last quarter. Menard Financial Group LLC purchased a new stake in Mettler-Toledo International in the fourth quarter valued at approximately $67,000. Finally, Blue Trust Inc. lifted its stake in Mettler-Toledo International by 520.0% in the first quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier’s stock valued at $73,000 after buying an additional 52 shares during the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, CFO Shawn Vadala sold 300 shares of the business’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the completion of the transaction, the chief financial officer owned 5,095 shares of the company’s stock, valued at approximately $6,750,875. The trade was a 5.56% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Thomas P. Salice sold 1,062 shares of the business’s stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the transaction, the director directly owned 283 shares of the company’s stock, valued at $368,154.70. This represents a 78.96% decrease in their position. The disclosure for this sale can be found here. Insiders sold 1,827 shares of company stock valued at $2,371,208 over the last quarter. Insiders own 1.94% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Barclays started coverage on Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an “overweight” rating and a $1,325.00 price objective for the company. Evercore ISI dropped their price objective on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating on the stock in a report on Monday, August 4th. Bank of America upped their target price on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a “neutral” rating in a report on Thursday, June 26th. Citigroup upped their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a report on Thursday, August 21st. Finally, Robert W. Baird increased their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a research note on Monday, August 4th. Five research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, Mettler-Toledo International currently has a consensus rating of “Moderate Buy” and a consensus target price of $1,311.11.

Mettler-Toledo International Stock Down 1.7%

Shares of NYSE MTD opened at $1,264.84 on Friday. Mettler-Toledo International, Inc. has a 52-week low of $946.69 and a 52-week high of $1,521.01. The stock has a market capitalization of $26.06 billion, a price-to-earnings ratio of 32.03, a PEG ratio of 3.80 and a beta of 1.37. The stock’s fifty day simple moving average is $1,264.75 and its 200 day simple moving average is $1,185.80.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, beating analysts’ consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business had revenue of $983.22 million for the quarter, compared to the consensus estimate of $957.41 million. During the same quarter in the previous year, the company posted $9.65 earnings per share. Mettler-Toledo International’s revenue for the quarter was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.